Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» TPX-0022
TPX-0022
Triple meeting – the point of turning to TPX-0022
EP Vantage
Tue, 10/27/20 - 10:32 am
Turning Point Therapeutics
repotrectinib
TPX-0022
non-small cell lung cancer